We are live on ! Find out more
PCM

Pointe Capital Management Portfolio holdings

AUM $202M
1-Year Est. Return 17.2%
This Fund
S&P 500
This Quarter Est. Return
-11.75%
1 Year Est. Return
+17.2%
3 Year Est. Return
+57.59%
5 Year Est. Return
+69.98%
10 Year Est. Return
+176.84%
AUM
$134M
AUM Growth
-$22.3M
Cap. Flow
-$8.51M
Cap. Flow %
-6.34%
Top 10 Hldgs %
39.51%
Holding
157
New
2
Increased
27
Reduced
34
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 11.09%
2 Energy 9.82%
3 Technology 5.57%
4 Healthcare 5.09%
5 Consumer Staples 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
151
NVIDIA
NVDA
$4.76T
-9,430
Closed -$257K
ORI icon
152
Old Republic International
ORI
$10.5B
-8,119
Closed -$210K
REGN icon
153
Regeneron Pharmaceuticals
REGN
$69.9B
-571
Closed -$399K
TRGP icon
154
Targa Resources
TRGP
$57.4B
-3,125
Closed -$236K
TRV icon
155
Travelers Companies
TRV
$81.4B
-1,100
Closed -$201K
TSLA icon
156
Tesla
TSLA
$1.22T
-675
Closed -$242K
AMJ
157
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-9,950
Closed -$208K

Similar funds

Pointe Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Pointe Capital Management held 157 positions worth $134M, down 14% from $157M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pointe Capital Management withdrew a net $8.51M in Q2 2022, closing 11 positions and reducing 34 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $399K position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Energy and Technology.

Against the trend, Pointe Capital Management opened a new position in FedEx worth $275K.

  • Pointe Capital Management's largest Q2 2022 buy was FedEx: 1,212 shares worth $275K.
  • Pointe Capital Management added most to iShares Russell 1000 Growth ETF in Q2 2022, an estimated $302K increase.
  • Pointe Capital Management's biggest Q2 2022 reduction was Eaton Vance Risk-Managed Diversified Equity Income Fund, cutting an estimated $5.88M.
  • Pointe Capital Management fully exited Regeneron Pharmaceuticals in Q2 2022, selling an estimated $399K.
  • Pointe Capital Management's ten largest holdings make up 40% of its $134M portfolio in Q2 2022.
  • Pointe Capital Management opened 2 new positions and closed 11 in Q2 2022.
  • Pointe Capital Management's portfolio value fell 14% quarter-over-quarter to $134M.

Based on Pointe Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.